234 related articles for article (PubMed ID: 29437913)
1. Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels.
Magro F; Lopes J; Borralho P; Lopes S; Coelho R; Cotter J; Castro FD; Sousa HT; Salgado M; Andrade P; Vieira AI; Figueiredo P; Caldeira P; Sousa A; Duarte MA; Ávila F; Silva J; Moleiro J; Mendes S; Giestas S; Ministro P; Sousa P; Gonçalves R; Gonçalves B; Oliveira A; Rosa I; Rodrigues M; Chagas C; Dias CC; Afonso J; Geboes K; Carneiro F;
Gut; 2019 Apr; 68(4):594-603. PubMed ID: 29437913
[TBL] [Abstract][Full Text] [Related]
2. Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels.
Magro F; Lopes J; Borralho P; Lopes S; Coelho R; Cotter J; Dias de Castro F; Tavares de Sousa H; Salgado M; Andrade P; Vieira AI; Figueiredo P; Caldeira P; Sousa A; Duarte MA; Ávila F; Silva J; Moleiro J; Mendes S; Giestas S; Ministro P; Sousa P; Gonçalves R; Gonçalves B; Oliveira A; Chagas C; Cravo M; Dias CC; Afonso J; Portela F; Santiago M; Geboes K; Carneiro F
J Crohns Colitis; 2020 Feb; 14(2):169-175. PubMed ID: 31504348
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Nancy Index With Continuous Geboes Score: Histological Remission and Response in Ulcerative Colitis.
Magro F; Lopes J; Borralho P; Dias CC; Afonso J; Ministro P; Santiago M; Geboes K; Carneiro F;
J Crohns Colitis; 2020 Jul; 14(7):1021-1025. PubMed ID: 31965158
[TBL] [Abstract][Full Text] [Related]
4. Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
Patel A; Panchal H; Dubinsky MC
Inflamm Bowel Dis; 2017 Sep; 23(9):1600-1604. PubMed ID: 28590341
[TBL] [Abstract][Full Text] [Related]
5. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
6. Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis.
Hart L; Chavannes M; Kherad O; Maedler C; Mourad N; Marcus V; Afif W; Bitton A; Lakatos PL; Brassard P; Bessissow T
J Crohns Colitis; 2020 Jan; 14(1):46-52. PubMed ID: 31314884
[TBL] [Abstract][Full Text] [Related]
7. Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients.
Cannatelli R; Bazarova A; Zardo D; Nardone OM; Shivaji U; Smith SCL; Gkoutos G; Ricci C; Gui XS; Ghosh S; Iacucci M
Inflamm Bowel Dis; 2021 Apr; 27(5):647-654. PubMed ID: 32592477
[TBL] [Abstract][Full Text] [Related]
8. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S
J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625
[TBL] [Abstract][Full Text] [Related]
9. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
[TBL] [Abstract][Full Text] [Related]
10. Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission.
Kawashima K; Oshima N; Kishimoto K; Kataoka M; Fukunaga M; Kotani S; Sonoyama H; Oka A; Mishima Y; Kazumori H; Ishikawa N; Araki A; Ishihara S
Inflamm Bowel Dis; 2023 Mar; 29(3):359-366. PubMed ID: 35583193
[TBL] [Abstract][Full Text] [Related]
11. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
[TBL] [Abstract][Full Text] [Related]
12. Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis.
Theede K; Holck S; Ibsen P; Ladelund S; Nordgaard-Lassen I; Nielsen AM
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1929-36.e1. PubMed ID: 26051392
[TBL] [Abstract][Full Text] [Related]
13. Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study.
Shimoyama T; Yamamoto T; Umegae S; Matsumoto K
BMC Gastroenterol; 2018 Aug; 18(1):120. PubMed ID: 30068300
[TBL] [Abstract][Full Text] [Related]
14. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.
Magro F; Lopes S; Coelho R; Cotter J; Dias de Castro F; Tavares de Sousa H; Salgado M; Andrade P; Vieira AI; Figueiredo P; Caldeira P; Sousa A; Duarte MA; Ávila F; Silva J; Moleiro J; Mendes S; Giestas S; Ministro P; Sousa P; Gonçalves R; Gonçalves B; Oliveira A; Chagas C; Torres J; Dias CC; Lopes J; Borralho P; Afonso J; Geboes K; Carneiro F;
J Crohns Colitis; 2017 Apr; 11(4):435-444. PubMed ID: 27664275
[TBL] [Abstract][Full Text] [Related]
16. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.
Fluxá D; Simian D; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Castro M; Piottante A; Vial MT; Quera R
J Dig Dis; 2017 Nov; 18(11):634-641. PubMed ID: 28949435
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis.
Malvão LDR; Madi K; Esberard BC; de Amorim RF; Silva KDS; Farias E Silva K; de Souza HSP; Carvalho ATP
Medicine (Baltimore); 2021 Jan; 100(3):e24058. PubMed ID: 33546007
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
19. Review article: faecal calprotectin and histologic remission in ulcerative colitis.
D'Amico F; Bonovas S; Danese S; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2020 Apr; 51(7):689-698. PubMed ID: 32048751
[TBL] [Abstract][Full Text] [Related]
20. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]